Find out what works well at Protara Therapeutics, Inc. from the people who know best. Get the inside scoop on jobs, salaries, top office locations, and CEO insights. Compare pay for popular roles and read about the team’s work-life balance. Uncover why Protara Therapeutics, Inc. is the best company for you.

2020-05-14 · PROTARA THERAPEUTICS AKTIE und aktueller Aktienkurs. Nachrichten zur Aktie Protara Therapeutics Inc Registered Shs | A2P4JE | TARA | US74365U1079

00:00. Contact · Careers · Market Hours · Glossary. © 2020 OTC Markets Group Inc. Terms of Service Linking Protara Therapeutics, Inc. Company Intro. Steadfast and tenacious in our search for transformative therapies TARA-002 for Lymphatic Malformations TARA-002 is See charts, data and financials for Protara Therapeutics Inc TARA. Budgeting · Banking and Credit · Taxes · Family Finance · Debt · Careers. BACK; Careers Stock quote and company snapshot for PROTARA THERAPEUTICS INC (TARA), including profile, stock chart, recent news and events, analyst opinions, and Latest Protara Therapeutics Inc (1KPA:BER) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.

Protara therapeutics careers

Uncover why Protara Therapeutics, Inc. is the best company for you. Protara is committed to identifying and advancing transformative therapies for people with rare and specialty diseases. Business Areas: Small Molecules, Rare Diseases Protara Therapeutics | Biotech Careers The Protara team prioritizes creativity, diverse perspectives and tenacity to expedite our goal of bringing life-changing therapies to people with limited treatment options. At Protara, we believe only by reflecting the world in which we live can we truly understand and treat cancer and rare diseases with significant unmet needs which often know no boundaries of age, gender, race, religion or 2021-03-12 · Protara is an Equal Opportunity Employer and is committed in policy and in practice to recruit, hire, train, and promote in all job qualifications without regard to race, color, religion, gender, age, national origin, citizenship status, marital status, sexual orientation, gender identity, disability and veteran status and any other protected characteristics under federal, state, or local laws. Protara Therapeutics, Inc. 345 Park Avenue South 3rd Floor New York, NY 10010 Phone: +1 646-844-0337 info@protaratx.com Dr. Julio Casoy has served as Protara’s Chief Medical Officer since February 2019 and brings over 35 years of experience in both development and commercialization expertise to Protara.

Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to … See the company profile for Protara Therapeutics, Inc. (TARA) including business summary, industry/sector information, number of employees, business … Jesse Shefferman is President/CEO at Protara Therapeutic Inc. See Jesse Shefferman's compensation, career history, education, & memberships. Protara Therapeutics, Inc. operates as a biotech company.

31 Dec 2020 PTC Therapeutics is a US pharmaceutical company focused on the development of orally administered small molecule drugs that regulate

Protara Therapeutics, Inc. 345 Park Avenue South 3rd Floor New York, NY 10010 Phone: +1 646-844-0337 info@protaratx.com Protara Therapeutics | 766 followers on LinkedIn | Steadfast and tenacious in our search for transformative therapies | Protara is committed to identifying and advancing transformative therapies Protara is committed to identifying and advancing transformative therapies for people with rare and specialty diseases. Business Areas: Small Molecules, Rare Diseases Protara Therapeutics | Biotech Careers BOARD OF DIRECTORS Protara is committed to identifying and advancing transformative therapies for people with cancer and rare diseases with limited treatment options. The Protara team prioritizes creativity, diverse perspectives and tenacity to expedite our goal of bringing life-changing therapies to people with limited treatment options. Protara is an Equal Opportunity Employer and is committed in policy and in practice to recruit, hire, train, and promote in all job qualifications without regard to race, color, religion, gender, age, national origin, citizenship status, marital status, sexual orientation, gender identity, disability and veteran status and any other protected Protara Therapeutics | 766 followers on LinkedIn | Steadfast and tenacious in our search for transformative therapies | Protara is committed to identifying and advancing transformative therapies Protara is committed to identifying and advancing transformative therapies for people with rare and specialty diseases.

Protara Therapeutics | 1,037 followers on LinkedIn. Steadfast and tenacious in our search for transformative therapies | Protara is committed to identifying and advancing transformative therapies

The Company is focused on developing treatments for rare and specialty diseases. Its development programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology/gastrointestinal and metabolic disorders.

Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income. Protara Therapeutics Announces Second Quarter 2020 Financial Results and Business Overview - read this article along with other careers information, tips and advice on BioSpace Protara Therapeutics, Inc., a development-stage company developing treatments for rare and specialty diseases with significant unmet needs, announced financial results for the second quarter ended June 30, 2020. See the company profile for Protara Therapeutics, Inc. (TARA) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases.
What is dictionary

Source: Protara Therapeutics Find the latest Protara Therapeutics, Inc. (TARA) stock quote, history, news and other vital information to help you with your stock trading and investing.

The company’s lead p About Us Company Careers Plans Login Help Center Simply Wall St News. Stock analysis for Protara Therapeutics Inc (TARA:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Protara Therapeutics Inc., formerly ArTara Therapeutics Inc., is a clinical-stage company. The Company is focused on developing treatments for rare and specialty diseases.
Postnord pacsoft online

Protara’s portfolio includes its lead program, TARA-002, an investigational cell-based therapy being developed for the treatment of non-muscle invasive bladder cancer and lymphatic malformations,

Jesse Shefferman is President/CEO at Protara Therapeutic Inc. See Jesse Shefferman's compensation, career history, education, & memberships. Protara Therapeutics, Inc. 345 Park Avenue South 3rd Floor New York, NY 10010 Phone: +1 646-844-0337 info@protaratx.com NEW YORK, Dec. 07, 2020 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases with significant unmet needs, today announced the promotion of Jacqueline (Jackie) Zummo, Ph.D., MPH, MBA from Senior Vice President, Research and Development Operations to Chief Scientific Operations NEW YORK, July 24, 2020 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical stage company developing treatments for rare and specialty diseases with significant unmet needs, today announced the appointment of Barry P. Flannelly, Pharm.D, to its Board of Directors. Protara Therapeutics develops transformative therapies for people with cancer and rare diseases. Protara’s portfolio includes its lead program, TARA-002, an investigational cell-based therapy created for the treatment of non-muscle invasive bladder cancer and lymphatic malformations, and IV Choline Chloride, an investigational phospholipid 2021-03-11 · Protara Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Business Overview - read this article along with other careers information, tips and advice on BioSpace 2020-10-02 · View the latest Protara Therapeutics Inc. (TARA) stock price, news, historical charts, analyst ratings and financial information from WSJ. 2021-02-02 · NEW YORK, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases Company profile page for Protara Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information 2020-07-24 · About Protara Therapeutics, Inc. Protara is committed to identifying and advancing transformative therapies for people with rare and specialty diseases who have limited treatment options. Protara Therapeutics New York, NY 10010, USA Full Time Protara’s portfolio includes its lead program, TARA-002, an investigational cell-based therapy being developed for the treatment of non-muscle invasive bladder cancer and lymphatic malformations, and IV Choline Chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure-associated liver 2020-05-11 · Protara Therapeutics Blaine.Davis@protaratx.com 646-844-0337. Media Contact Karen O’Shea, Ph.D. LifeSci Communications koshea@lifescicomms.com 929-469-3860 Protara Therapeutics Announces Appointment of Barry P. Flannelly to Board of Directors - read this article along with other careers information, tips and advice on BioSpace Protara Therapeutics, Inc. announced the appointment of Barry P. Flannelly, Pharm.D, to its Board of Directors.

2021-04-10

Protara is an Equal Opportunity Employer and is committed in policy and in practice to recruit, hire, train, and promote in all job qualifications without regard to race, color, religion, gender, age, national origin, citizenship status, marital status, sexual orientation, gender identity, disability and veteran status and any other protected Protara Therapeutics | 766 followers on LinkedIn | Steadfast and tenacious in our search for transformative therapies | Protara is committed to identifying and advancing transformative therapies Protara is committed to identifying and advancing transformative therapies for people with rare and specialty diseases.

See the company profile for Protara Therapeutics, Inc. (TARA) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. Köp aktier i Protara Therapeutics Inc - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage.